Matches in DBpedia 2014 for { ?s ?p Imiquimod (INN) is a prescription medication that acts as an immune response modifier. It is marketed by Meda AB, Graceway Pharmaceuticals, and iNova Pharmaceuticals under the trade names Aldara and Zyclara, and by Mochida as Beselna. It is also referred to as R-837. Due to the bankruptcy of Graceway in 2011, Medicis Pharmaceutical Corporation is the current owner of these products.. }
Showing items 1 to 2 of
2
with 100 items per page.
- Imiquimod abstract "Imiquimod (INN) is a prescription medication that acts as an immune response modifier. It is marketed by Meda AB, Graceway Pharmaceuticals, and iNova Pharmaceuticals under the trade names Aldara and Zyclara, and by Mochida as Beselna. It is also referred to as R-837. Due to the bankruptcy of Graceway in 2011, Medicis Pharmaceutical Corporation is the current owner of these products.".
- Imiquimod comment "Imiquimod (INN) is a prescription medication that acts as an immune response modifier. It is marketed by Meda AB, Graceway Pharmaceuticals, and iNova Pharmaceuticals under the trade names Aldara and Zyclara, and by Mochida as Beselna. It is also referred to as R-837. Due to the bankruptcy of Graceway in 2011, Medicis Pharmaceutical Corporation is the current owner of these products.".